Allogene Therapeutics, Inc. (ALLO) SEC Filings — 2025
10 SEC filings for Allogene Therapeutics, Inc. (ALLO) in 2025.
Filings
- Allogene Narrows Q3 Loss Amid R&D Cuts, Eyes Further Capital — 10-Q · Nov 6, 2025
- Allogene Therapeutics Files 8-K for Other Event — 8-K · Oct 14, 2025
- Allogene Narrows Q2 Loss Amid R&D Cuts, Eyes Future Capital Raise — 10-Q · Aug 13, 2025
- Allogene Therapeutics Files 8-K — 8-K · Aug 1, 2025
- Allogene Therapeutics Files 8-K on Shareholder Vote & Exhibits — 8-K · Jun 23, 2025
- Allogene Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
- Allogene Therapeutics Files Proxy Materials — DEFA14A · Apr 30, 2025
- Allogene Therapeutics Files 2024 10-K — 10-K · Mar 13, 2025
- Allogene Therapeutics Enters Material Definitive Agreement — 8-K · Feb 25, 2025
- Allogene Therapeutics Announces Board and Compensation Changes — 8-K · Jan 29, 2025